Last Updated: November 9, 2026

CEFUROXIME SODIUM IN PLASTIC CONTAINER Drug Patent Profile

« Back to Dashboard


Which patents cover Cefuroxime Sodium In Plastic Container, and when can generic versions of Cefuroxime Sodium In Plastic Container launch?

Cefuroxime Sodium In Plastic Container is a drug marketed by Samson Medcl and is included in one NDA.

The generic ingredient in CEFUROXIME SODIUM IN PLASTIC CONTAINER is cefuroxime sodium. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the cefuroxime sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cefuroxime Sodium In Plastic Container

A generic version of CEFUROXIME SODIUM IN PLASTIC CONTAINER was approved as cefuroxime sodium by ACS DOBFAR SPA on May 30th, 1997.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for CEFUROXIME SODIUM IN PLASTIC CONTAINER?
  • What are the global sales for CEFUROXIME SODIUM IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for CEFUROXIME SODIUM IN PLASTIC CONTAINER?
Summary for CEFUROXIME SODIUM IN PLASTIC CONTAINER
Recent Clinical Trials for CEFUROXIME SODIUM IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The George InstitutePHASE3
Turku University HospitalPHASE3
Helsinki University Central HospitalPHASE3

See all CEFUROXIME SODIUM IN PLASTIC CONTAINER clinical trials

US Patents and Regulatory Information for CEFUROXIME SODIUM IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Samson Medcl CEFUROXIME SODIUM IN PLASTIC CONTAINER cefuroxime sodium INJECTABLE;INJECTION 065251-001 Dec 30, 2009 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Samson Medcl CEFUROXIME SODIUM IN PLASTIC CONTAINER cefuroxime sodium INJECTABLE;INJECTION 065251-002 Dec 30, 2009 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.